Leads on a cure for chronic pain

Issue: BCMJ, vol. 56 , No. 4 , May 2014 , Pages 178 News

Dr Brian Cairns, professor in the Faculty of Pharmaceutical Sciences at UBC, studies chronic pain above the neck—migraines and temporomandibular disorders, which cause soreness in the jaw—and is tracking intriguing leads in his search for pain relief. These jaw disorders affect about 10% of people at some point in their life and the pain can be so intense that it becomes difficult to speak or eat. Recently Dr Cairns stumbled across a clue to what might be causing this discomfort.

Glutamate is a neurotransmitter that sends signals between nerve and brain cells. It occurs naturally in the brain and body but may also be consumed in food (monosodium glutamate). The average fast-food meal contains 12 grams of glutamate. Dr Cairns heard about research showing that glutamate activates receptors in the brain, and he knew these receptors are also found around the eyes and in skin and muscles, and, when activated, cause pain. His research led him to wonder if eating glutamate caused pain and he asked young, healthy people to ingest 12 grams of the amino acid and watched what happened. The experiment induced headaches, nausea, or jaw pain about 50% to 60% of the time.

He also convinced patients with temporomandibular disorders to let his team stick a needle through their cheeks to measure glutamate levels in their jaw muscles and found higher levels of glutamate where the muscles were most painful.

Dr Cairns suspects if glutamate levels spike in an area around the nerves in the head it triggers headaches, such as migraines, so his idea is to develop a drug that reduces glutamate levels in this area. For more information on the research Dr Cairns is involved in, visit www.pharmacy.ubc.ca/research/researchers/brian-cairns.

. Leads on a cure for chronic pain. BCMJ, Vol. 56, No. 4, May, 2014, Page(s) 178 - News.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply